Cell Ready, LLC entered into a purchase agreement to acquire Certain Cell Manufacturing Assets of Marker Therapeutics, Inc. for $19 million on May 1, 2023. Transaction is expected to close on June 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.165 USD | +3.60% | +20.02% | -24.28% |
15/05 | Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M | MT |
15/05 | Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.28% | 3.71Cr | |
+40.80% | 5.37TCr | |
+35.79% | 3.89TCr | |
-8.05% | 3.88TCr | |
-8.98% | 2.73TCr | |
+10.69% | 2.59TCr | |
-16.21% | 2.03TCr | |
+31.00% | 1.28TCr | |
+28.51% | 1.22TCr | |
-1.67% | 1.2TCr |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Cell Ready, LLC entered into a purchase agreement to acquire Certain Cell Manufacturing Assets of Marker Therapeutics, Inc. for $19 million.